CYTOKINES CONTRIBUTE TO AIRWAY DYSFUNCTION IN ANTIGEN-CHALLENGED GUINEA-PIGS - INHIBITION OF AIRWAY HYPERREACTIVITY, PULMONARY EOSINOPHIL ACCUMULATION, AND TUMOR-NECROSIS-FACTOR GENERATION BY PRETREATMENT WITH AN INTERLEUKIN-1 RECEPTOR ANTAGONIST

被引:113
作者
WATSON, ML [1 ]
SMITH, D [1 ]
BOURNE, AD [1 ]
THOMPSON, RC [1 ]
WESTWICK, J [1 ]
机构
[1] SYNERGEN,BOULDER,CO
基金
英国惠康基金;
关键词
D O I
10.1165/ajrcmb/8.4.365
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The role of pro-inflammatory cytokines in an animal model of allergic lung disease was examined by use of an interleukin-1 receptor antagonist (IL-1ra) and a specific bioassay for tumor necrosis factor (TNF). Ovalbumin-sensitized guinea pigs exhibit a marked bronchial hyperreactivity (assessed by airway responsiveness to intravenous histamine) and pulmonary eosinophil accumulation (assessed by bronchoalveolar lavage) 24 h after challenge with aerosolized antigen. Exposure of animals to an aerosol of IL-1ra (50 mug over 30 min) immediately before antigen challenge resulted in a marked protection against bronchial hyperreactivity and pulmonary eosinophil accumulation compared with IL-1ra vehicle-pretreated animals. Additionally, we report for the first time generation of TNF bioactivity in the bronchoalveolar lavage of antigen-challenged animals, which was significantly reduced in animals exposed to aerosolized IL-1ra before challenge. These studies point to a key role for the cytokines IL-1 and possibly TNF in the pulmonary changes observed during allergic airway disease.
引用
收藏
页码:365 / 369
页数:5
相关论文
共 39 条
  • [1] INTERLEUKIN-1 IS RELEASED AT SITES OF HUMAN CUTANEOUS ALLERGIC REACTIONS
    BOCHNER, BS
    CHARLESWORTH, EN
    LICHTENSTEIN, LM
    DERSE, CP
    GILLIS, S
    DINARELLO, CA
    SCHLEIMER, RP
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1990, 86 (06) : 830 - 839
  • [2] INTERLEUKIN-3-DEPENDENT AND INTERLEUKIN-3-INDEPENDENT MAST-CELLS STIMULATED WITH IGE AND ANTIGEN EXPRESS MULTIPLE CYTOKINES
    BURD, PR
    ROGERS, HW
    GORDON, JR
    MARTIN, CA
    JAYARAMAN, S
    WILSON, SD
    DVORAK, AM
    GALLI, SJ
    DORF, ME
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (01) : 245 - 257
  • [3] BURROWS L J, 1991, Fundamental and Clinical Pharmacology, V5, P405
  • [4] DEMONCHY JGR, 1985, AM REV RESPIR DIS, V131, P373
  • [5] PRIMARY STRUCTURE AND FUNCTIONAL EXPRESSION FROM COMPLEMENTARY-DNA OF A HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST
    EISENBERG, SP
    EVANS, RJ
    AREND, WP
    VERDERBER, E
    BREWER, MT
    HANNUM, CH
    THOMPSON, RC
    [J]. NATURE, 1990, 343 (6256) : 341 - 346
  • [6] A HIGHLY SENSITIVE CELL-LINE, WEHI-164 CLONE 13, FOR MEASURING CYTOTOXIC FACTOR TUMOR-NECROSIS-FACTOR FROM HUMAN-MONOCYTES
    ESPEVIK, T
    NISSENMEYER, J
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 95 (01) : 99 - 105
  • [7] FAHERTY DA, 1992, J IMMUNOL, V148, P766
  • [8] MAST-CELLS AS A SOURCE OF BOTH PREFORMED AND IMMUNOLOGICALLY INDUCIBLE TNF-ALPHA CACHECTIN
    GORDON, JR
    GALLI, SJ
    [J]. NATURE, 1990, 346 (6281) : 274 - 276
  • [9] INCREASED SECRETION OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-6 BY ALVEOLAR MACROPHAGES CONSECUTIVE TO THE DEVELOPMENT OF THE LATE ASTHMATIC REACTION
    GOSSET, P
    TSICOPOULOS, A
    WALLAERT, B
    VANNIMENUS, C
    JOSEPH, M
    TONNEL, AB
    CAPRON, A
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1991, 88 (04) : 561 - 571
  • [10] GRAZIANO F, 1981, J IMMUNOL, V127, P1067